CHRS
Coherus Oncology, Inc.Company with tickers: CHRS
CIK
1512762
CUSIP
19249H103
Shares Outstanding
154,249,900
13F Activity (30d)
140 filings
135 filers
Price
$1.63
Market Cap
$248.34M
P/E Ratio
1.14
EPS (Diluted)
$1.43
52W High
$2.62
52W Low
$0.71
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $21,543,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-36,151,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-38,327,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.28 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.28 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |